Adenoviral mediated MyoD gene transfer into fibroblasts: Myogenic disease diagnosis

Brain and Development

Volumn 28, Issue 7, 2006, Pages 420-425

  Fujii, Isao ^a,b   Matsukura, Makoto ^a,b   Ikezawa, Makoto ^b   Suzuki, Satoru ^c   Shimada, Takashi ^c   Miike, Teruhisa ^b  

^a Division of Clinical Pharmacy   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Genetic diagnosis; Muscular disease; MyoD; Myogenesis

Indexed keywords

ADENINE; ADENOVIRUS VECTOR; CYTOSINE; DESMIN; DYSTROPHIN; GUANINE; MYOD PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL DISORDER; DIAGNOSTIC VALUE; GENE TRANSFER; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MUSCLE DEVELOPMENT; MUSCLE DISEASE; MYOTUBE; PRESCHOOL CHILD; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RELIABILITY; SKIN FIBROBLAST; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; WESTERN BLOTTING;

ADENOVIRIDAE; BLOTTING, WESTERN; CELLS, CULTURED; CHILD, PRESCHOOL; DESMIN; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCULAR DYSTROPHY, DUCHENNE; MYOD PROTEIN; TIME FACTORS;

EID: 33745478841     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2005.12.007     Document Type: Article

References (33)

1. Ikezawa M., Minami N., Takahashi Y., Goto Y., Miike T., and Nonaka I. Dystrophin gene analysis on 130 patients with Duchenne muscular dystrophy with a special reference to muscle mRNA analysis. Brain Dev 20 (1998) 165-168
2. Wedel D.J. Malignant hyperthermia and neuromuscular disease. Neuromuscul Disord 2 (1992) 157-164
3. Kawamura J. Detection of mutation in dystrophin gene in Duchenne muscular dystrophy-multiplex PCR and southern blot analysis (in Japanese). Nippon Rinsho Jpn 55 (1997) 3126-3130
4. Roest P.A., Bakker E., Fallaux F.J., Verellen-Dumoulin C., Murry C.E., and den Dunnen J.T. New possibilities for prenatal diagnosis of muscular dystrophies: forced myogenesis with an adenoviral MyoD-vector. Lancet 353 (1999) 727-728
5. Ishikawa Y., Ishikawa Y., and Minami R. Forced myogenesis with a retroviral MyoD-vector in human fibroblasts and dystrophin expression (in Japanese). No To Hattatsu Tokyo 25 (2003) 426-428
6. Kimura S., Ito K., Miyagi T., Hiranuma T., Yoshioka K., Ozasa S., et al. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy. Brain Dev 27 (2005) 400-405
7. Weintraub H., Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86 (1989) 5434-5438
8. Murry C.E., Kay M.A., Bartosek T., Hauschka S.D., and Schwartz S.M. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest 98 (1996) 2209-2217
9. Lattanzi L., Salvatori G., Coletta M., Sonnino C., Cusella De Angelis M.G., Gioglio L., et al. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 101 (1998) 2119-2128
10. Sancho S., Mongini T., Tanji K., Tapscott S.J., Walker W.F., Weintraub H., et al. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. N Engl J Med 329 (1993) 915-920
11. Olson E.N., and Klein W.H. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 8 (1994) 1-8
12. Rudnicki M.A., and Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17 (1995) 203-209
13. Lopez-Casillas F., Riquelme C., Perez-Kato Y., Ponce-Castaneda M.V., Osses N., Esparza-Lopez J., et al. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J Biol Chem 278 (2003) 382-390
14. Lassar A.B., Paterson B.M., and Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47 (1986) 649-656
15. Yuasa K., Miyagoe Y., Yamamoto K., Nabeshima Y., Dickson G., and Takeda S. Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs. Fed Eur Biochem Soc Lett 425 (1998) 329-336
16. Fujii I., Suzuki S., Igarashi T., Matsukura M., and Miike T. Shimada Targeted and stable gene delivery into muscle cells by a two-step transfer system. Biochem Biophys Res Commun 275 (2000) 931-935
17. Kanegae Y., Makimura M., and Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47 (1994) 157-166
18. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251 (1991) 761-766
19. Capetanaki Y., Milner D.J., and Weitzer G. Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct 22 (1997) 103-116
20. Hoffman E.P., Brown R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Biotechnology 24 (1992) 457-466
21. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. Fed Eur Biochem Soc Lett 407 (1997) 313-319
22. Davis R.L., Cheng P.F., Lassar A.B., and Weintraub H. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60 (1990) 733-746
23. Marshall P., Chartrand N., and Worton R.G. The mouse dystrophin enhancer is regulated by MyoD, E-box-binding factors, and by the serum response factor. J Biol Chem 276 (2001) 20719-20726
24. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 (1995) 1018-1021
25. Nonaka I. Pathophysiology in muscle fiber necrosis and regeneration with a particular reference to regenerating process (in Japanese). Rinsho Shinkeigaku Clin Neurol 38 (1998) 997-1000
26. Morral N., O'Neal W., Zhou H., Langston C., and Beaudet A. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum Gene Ther 8 (1997) 1275-1286
27. Yang L., Lochmuller H., Luo J., Massie B., Nalbantoglu J., Karpati G., et al. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther 5 (1998) 369-379
28. Holt K.H., and Campbell K.P. Assembly of the sarcoglycan complex. Insights for muscular dystrophy. J Biol Chem 273 (1998) 34667-34670
29. Jones K.J., Kim S.S., and North K.N. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies. J Med Genet 35 (1998) 379-386
30. Kekou K., Florentin L., and Metaxotou C. 3′ Acceptor splice site mutation in intron 50 leads to mild Duchenne muscular dystrophy phenotype. Hum Mutat 1 Suppl. (1998) S209-S212
31. Kimura S., Fujishita S., Ikezawa M., Ogawa M., Abe K., and Miike T. Muscle type promoter and its first intron abnormalities in dystrophin gene in patients with Duchenne muscular dystrophy. J Child Neurol 13 (1998) 290-292
32. Ikezawa M., Nishino I., Goto Y., Miike T., and Nonaka I. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the Dystrophin gene resulting in Duchenne muscular dystrophy. Hum Mutat 13 (1999) 170
33. Sancho S., Mongini T., Tanji K., Tapscott S.J., Walker W.F., Weintraub H., et al. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. N Engl J Med 329 (1993) 915-920